Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
H100 Group ABFRA:GS9 35 Debt-to-Equity is 0.09 as of Dec. 2025, which is at its 10-year median of 0.09. GuruFocus rates FRA:GS9 with a GF Score™ of 35/100. The stock has 2 warning signs investors should review. Among 556 Healthcare Providers & Services companies, H100 Group AB ranks better than 80.22% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for H100 Group AB's Debt-to-Equity or its related term are showing as below:
FRA:GS9'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.09 Med: 0.09 Max: 0.09
Current: 0.09
During the past 8 years, the highest Debt-to-Equity Ratio of H100 Group AB was 0.09. The lowest was 0.09. And the median was 0.09.
FRA:GS9's Debt-to-Equity is ranked better than 80.22% of 556
companies
in the Healthcare Providers & Services industry
Industry Median: 0.405
vs FRA:GS9: 0.09
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
H100 Group AB Debt-to-Equity Related Terms
H100 Group AB Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for H100 Group AB's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:GS9 vs VEEV, BTSG, HQY: Debt-to-Equity Comparison
For the Health Information Services subindustry, H100 Group AB's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
H100 Group AB Debt-to-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, H100 Group AB's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where H100 Group AB's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
H100 Group AB (FRA:GS9) has a Debt-to-Equity of 0.09 as of Dec. 2025. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on H100 Group AB and its competitors. This is near median its historical median of 0.09. Over the past decade, H100 Group AB's Debt-to-Equity has ranged from 0.09 to 0.09. According to the industry distribution chart, H100 Group AB ranks #110 out of 556 companies in the Healthcare Providers & Services industry, placing it in the top 19.8%.
Is H100 Group AB's Debt-to-Equity too high?
H100 Group AB's current Debt-to-Equity of 0.09 is near median its 10-year median of 0.09. Over the past 10 years, this metric has ranged from a low of 0.09 to a high of 0.09. The Healthcare Providers & Services industry median Debt-to-Equity is 0.41. H100 Group AB's value of 0.09 is 77.8% below this industry median. Based on the distribution chart, H100 Group AB ranks #110 out of 556 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, H100 Group AB has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does H100 Group AB's Debt-to-Equity compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, H100 Group AB ranks #110 out of 556 companies for Debt-to-Equity. This places H100 Group AB in the top 20% of its industry — outperforming the majority of peers. The industry median Debt-to-Equity is 0.41. H100 Group AB's value of 0.09 is 77.8% below this benchmark. Historically, H100 Group AB's own Debt-to-Equity has ranged from 0.09 to 0.09 over the past decade. While the company's 10-year median is 0.09 vs. the industry median of 0.41, H100 Group AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Healthcare Providers & Services company?
The median Debt-to-Equity among Healthcare Providers & Services companies is 0.41, based on 556 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. H100 Group AB's current Debt-to-Equity of 0.09 is 77.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on H100 Group AB and its competitors. For the Healthcare Providers & Services industry, the median Debt-to-Equity is 0.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. H100 Group AB's current Debt-to-Equity is 0.09, which is near median its own 10-year median of 0.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is H100 Group AB stock overvalued right now?
H100 Group AB (FRA:GS9) has a current Debt-to-Equity of 0.09. The current Debt-to-Equity is 0.09, which is near median its 10-year median of 0.09 and 77.8% below the Healthcare Providers & Services industry median of 0.41. H100 Group AB's overall GF Score™ is 35/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For H100 Group AB (FRA:GS9), the current Debt-to-Equity is 0.09 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
H100 Group AB is a Swedish health technology company and the Bitcoin Treasury Company in the Nordics. The Company's objective is to maximize Bitcoin exposure per share by expanding its Bitcoin treasury through financial instruments. The Company operates through two business areas: Bitcoin Treasury operations, which focus on increasing Bitcoin exposure per share through strategic and financial instruments, and a health-tech division that supports health and longevity providers with AI-powered automation and growth tools. The Company generates revenue from digital services related to training and nutrition coaching provided to B2C customers and SaaS revenue related to the Group's digital platform provided to B2B customers. It operates in Sweden and Norway.
35GF Score
Get the complete analysis for FRA:GS9
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:GS9 has been successfully added to your 
